Biohaven reports positive topline results from zydis study
Biohaven Pharmaceutical has reported positive topline results from the Phase III BHV3000-303 or Study 303...
Biohaven Pharmaceutical has reported positive topline results from the Phase III BHV3000-303 or Study 303...